🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Scott Isaacs OR.... A high number of patients must be evaluated using the OWLiver Panel. One-step screening strategy with OWLiver Panel has high accuracy to detect MASH and at-risk MASH in high-risk subjects for MASLD (UEG, in press). Paula Iruzubieta @OWLMetabolomics Cristina Alonso

We're excited to announce our scientific contribution at the #EASLCongress 2024! Our poster SAT-429, providing stronger evidence for the use of #MASEF score for identifying patients with at-risk-MASH will be presented on June 8th. #EASL2024 #Metabolomics Keep on reading👇

Great publication by Nick Davidson team. Congratulations!!! Proud to have been part of this project.

After so many years attending #EASLCongress & #TheLiverMeeting, I am happy to be at my first #ADASciSessions. I'm ready for poster session (1326-P). Thank you Marco Arrese, MD Patricia Aspichueta Jesus Bañales for your support.

Up next, Dr. Pedro Rodrigues Pedro Rodrigues introducing novel biomarkers for early diagnosis and discussing the role of metabolomics in BTC diagnosis #PrecisionBTCNet #ENSCCA #Krakow2024 🔬🇵🇱

We are excited to kick off the "Workshop with Industry" at NOVA Medical School. Over the next two days, we'll be diving deep into knowledge transfer, promoting translation, and fostering collaborations with industry. Stay tuned for updates and highlights from the event!📸

In the final session, moderated by Pedro Cruz and Joao Conde, participants engaged in a round table discussion on how to promote translation and foster collaborations with industry. Thank you all for engaging in this amazing discussion!

Thank you EVCA Twinning Project for the invitation and for promoting this workshop! A great initiative! #OWLteam

Congrats to EVCA Twinning Project for the “Workshop with industry” held in Lisbon this week. #OWLteam contributes our experience and industry-driven point of view, supporting a new generation of translationally minded scientists! #EVCATwinning #HorizonEU #Metabolomics #OWLMetabolomics

2⃣A one‐step screening strategy using the OWLiver Panel can accurately predict the presence of MASH and at‐risk MASH in subjects at high risk of MASH progression. Paula Iruzubieta Rebeca Mayte Arias Loste Javier Ampuero Agustín Albillos Jose Luis Calleja Manuel Romero-Gómez RAF Asociación Española para el Estudio del Hígado

Diagnosis of #MASLD in a single step is possible, especially in the most at-risk populations. 🚩We should implement it now in endocrinologist, internal medicine and primary care consultations. 🚩 EASLnews AASLD Manuel Romero-Gómez Jose Luis Calleja Paula Iruzubieta @OWLMetabolomics

📊At @OWLMetabolomics, we're proud to present our latest research: "Genetic Algorithms Applied to Translational Strategy in Metabolic-Dysfunction Associated Steatohepatitis (MASH). Learning from Mouse Models," led by Ibon Martínez-Arranz. Keep on reading 👇

Hace años que sabemos que el riesgo vascular no es homogéneo en los pacientes con #MASLD y que la metabolómica puede diferenciar los perfiles de riesgo cardiovascular. ¿Por qué usamos este conocimiento? Sociedad Española de Patología Digestiva (SEPD) Asociación Española para el Estudio del Hígado EASLnews pubmed.ncbi.nlm.nih.gov/35220605/

Back home after a fantastic #TLM24! Good science, great venue & surrounded by great friends! Thanks to everyone who visited our🏅Poster of Distinction on the robustness of #MASEF score for diagnosing patients with at-risk MASH on lipid-lowering therapy. 🔝 collaborators!

Cristina Alonso Marco Arrese, MD Jesus Bañales Mazen Noureddin, MD, MHSc @OWLMetabolomics AASLD EASLnews ALEH Asociación Española para el Estudio del Hígado Sociedad Española de Patología Digestiva (SEPD) Early identification of at-risk MASH is essential, and the MASEF® Score is recommended as a reliable NIT. Its performance remains consistent regardless of lipid-lowering therapies, supporting its integration into clinical practice Paula Iruzubieta Cristina Alonso @OWLMetabolomics

#EASLCongress General Session 2 Pedro Rodrigues presents a novel 3-in-1 blood metabolomic test for the early diagnosis & risk stratification of PSC & CCA 👏🏼👏🏼👏🏼 Jesus Bañales EASLnews

Terrific presentation! Big congrats to Pedro Rodrigues and Liver Diseases team at Biogipuzkoa

Amazing presentation of Pedro Rodrigues this morning in the General Session 2 at #EASLCongress: Novel 3-in-1 metabolomic test for early diagnosis & risk stratification of PSC & CCA. Well deserved Best Oral Clinical presentation! 👏👏 Big congrats to all the team & collaborators.

We’re at the European Congress on Obesity (ECO) 2025 in Málaga! 📅 May 11–14 🔖 #ECO2025 Meet Haroon Allybacus & Cristina Alonso as we dive into liver health & metabolic innovation. 📩 Email us at [email protected] to connect!